tirzepatide blurry vision Can Cause Blindness? What to Know Diabetes: Tirzepatide May Lower Risk

A diverse gut microbiome is a resilient one

This discussion should consider the individual's overall health, risk factors, and therapeutic options to make an informed decision about whether to continue or discontinue GLP-1 drugs

By staying informed about this medication and its administration process, youll be better equipped to provide optimal care to your patients living with type 2 diabetes

However, in this trial, weight loss response to semaglutide 2.4 mg at 68 weeks was not related to meal-stimulated endogenous GLP-1 response at baseline, suggesting that the supraphysiological effect of semaglutide probably overrides the biological mechanisms linked to a suboptimal clinical response

Quick answer: when GLP 1 therapy is and is not the right tool GLP 1 therapy can be a strong option when menopause weight gain is tied to insulin resistance, appetite dysregulation, visceral fat gain, or repeated plateaus despite consistent habits